Most brand owners picture custom formulation as a chemist picking great ingredients. That part matters, but it is the smallest part. A custom formula is a set of decisions that have to survive the label, the capsule or scoop size, the shelf, the batch record and an FDA inspection. If one of those decisions is wrong, it shows up later as a product that doesn’t fit its format, a label you can’t support, or a reformulation after launch.
This guide walks through what actually happens between your first brief and the first commercial batch, so you know what to bring, what to ask and what to approve at each step.
A custom formula is built for your product: your target customer, your dose per serving, your format and your price per unit. It is different from adapting an existing formula you already own, which is a supplement tech transfer. In both cases the manufacturer has to turn the idea into something it can produce the same way, batch after batch, under cGMP for dietary supplements (21 CFR Part 111).
The quality of the formula depends on the quality of the brief. A useful brief answers these questions:
The clearer these answers are, the fewer rounds of samples you will need.
For each ingredient, the formulator chooses a specific form and grade, not just a name. “Magnesium” can mean very different raw materials with different elemental content, solubility and cost; we compared two common forms in magnesium glycinate vs. oxide.
This is also when regulatory status gets checked. If an ingredient qualifies as a new dietary ingredient that has not been present in the food supply in an unaltered form, the manufacturer or distributor must notify FDA at least 75 days before introducing the supplement into interstate commerce (21 CFR 190.6). Discovering that requirement after the launch date is set is an expensive surprise.
The number on the Supplement Facts panel is a promise the finished product has to keep for its whole shelf life. FDA’s rules set the floor:
The same section states that reasonable excesses over labeled amounts are acceptable within current good manufacturing practice. That is the basis for overages: adding a measured excess of an ingredient that degrades over time, so the product still meets its label at the end of shelf life. Overages should be set with data, not guesswork, which is why they connect directly to shelf-life and stability testing.
A formula that works on paper can still fail the format. Common issues:
| Format | What the formula has to solve |
|---|---|
| Capsules | Total fill weight per serving versus capsule size and the number of capsules you will ask customers to take. At UniWell we fill sizes 1, 0, 00 and 00EL. |
| Tablets | Compressibility, hardness and disintegration; the excipients needed to hold a high dose together. |
| Powders, stick packs and sachets | Flowability for accurate filling, blend uniformity, mixability and taste in one exact serving. |
| Liquids | Solubility, taste masking and stability of the actives in solution. |
If the full dose doesn’t fit, there are only a few honest options: more units per serving, a different format, or a different dose on the label. A good formulator raises this before samples, not after.
Taste is part of fit for chewables, powders and liquids. Bitter or mineral notes need masking that works at the real dose, which is the job of flavor development.
Before production, the formula becomes a set of written specifications. Under cGMP the manufacturer must establish, for each component, an identity specification, the specifications needed to meet the purity, strength and composition of the finished supplement, and limits on contamination that could adulterate the batch (21 CFR 111.70(b)). Each dietary ingredient has to be tested or examined to verify its identity before use, unless FDA grants an exemption (21 CFR 111.75(a)(1)).
For a brand owner, specifications are where the formula becomes enforceable. They define what each batch must meet and what shows up on the certificate of analysis.
Bench samples let you evaluate taste, color, size and mixability. Once a sample is approved, the formula is scaled into a master manufacturing record and run as a first batch. What you should approve along the way:
Agree on ownership in writing before development starts, not after the product sells. We cover what to put in the agreement in who owns your supplement formula.
A clear brief: target customer, intended benefit and claims, format, the ingredients and amounts you want on the label, target cost per unit and expected launch volume. The more specific the brief, the fewer sample rounds you need.
Overages are measured excesses of an ingredient added so the product still meets its declared amount at the end of shelf life. FDA’s labeling rule states that reasonable excesses over labeled amounts are acceptable within cGMP (21 CFR 101.36(f)(1)).
A custom formula is developed for your product from your brief. A tech transfer moves a formula you already own to a new manufacturer, which has to reproduce it under its own specifications and records.
Developing a new supplement? UniWell Labs formulates and manufactures capsules, tablets, powders, stick packs, sachets and liquids for brand owners under cGMP in Texas. See how our supplement contract manufacturing process works, from formulation to batch release.
Share your brief and our team will walk you through formulation, specifications and samples.